Literature DB >> 22172419

Core myopathies.

Heinz Jungbluth1, Caroline A Sewry, Francesco Muntoni.   

Abstract

The core myopathies, Central Core Disease and Multiminicore Disease, are heterogeneous congenital myopathies with the common defining histopathological feature of focally reduced oxidative enzyme activity (central cores, multiminicores). Mutations in the gene encoding for the skeletal muscle ryanodine (RyR1) receptor are the most common cause. Mutations in the selenoprotein N (SEPN1) gene cause a less common variant. Pathogenic mechanisms underlying dominant RYR1 mutations have been extensively characterized, whereas those associated with recessive RYR1 and SEPN1 mutations are emerging. Identifying a specific genetic defect from the histopathological diagnosis of a core myopathy is complex and ought to be informed by a combined appraisal of histopathological, clinical, and, increasingly, muscle magnetic resonance imaging data. The present review aims at giving an overview of the main genetic and clinicopathological findings, with a major emphasis on features likely to inform the diagnostic process, as well as current treatments and perspectives for future research.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172419     DOI: 10.1016/j.spen.2011.10.005

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  44 in total

1.  Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies.

Authors:  Christoph Bachmann; Faiza Noreen; Nicol C Voermans; Primo L Schär; John Vissing; Johanna M Fock; Saskia Bulk; Benno Kusters; Steven A Moore; Alan H Beggs; Katherine D Mathews; Megan Meyer; Casie A Genetti; Giovanni Meola; Rosanna Cardani; Emma Mathews; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato; Susan Treves
Journal:  Hum Mutat       Date:  2019-04-01       Impact factor: 4.878

Review 2.  Prominent myalgia-an important clue in the diagnosis of a muscle disorder.

Authors:  Puneet Jain; Vineet Sehgal
Journal:  World J Pediatr       Date:  2017-06       Impact factor: 2.764

3.  Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy.

Authors:  Daniel C Helbling; David Mendoza; Julie McCarrier; Mark A Vanden Avond; Matthew M Harmelink; Paul E Barkhaus; Donald Basel; Michael W Lawlor
Journal:  J Neuropathol Exp Neurol       Date:  2019-03-01       Impact factor: 3.685

4.  Mouse model of severe recessive RYR1-related myopathy.

Authors:  Stephanie Brennan; Maricela Garcia-Castañeda; Antonio Michelucci; Nesrin Sabha; Sundeep Malik; Linda Groom; Lan Wei LaPierre; James J Dowling; Robert T Dirksen
Journal:  Hum Mol Genet       Date:  2019-09-15       Impact factor: 6.150

Review 5.  Muscle biopsy evaluation in neuromuscular disorders.

Authors:  Nanette C Joyce; Björn Oskarsson; Lee-Way Jin
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

Review 6.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

7.  A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.

Authors:  Sissel Løseth; Nicol C Voermans; Torberg Torbergsen; Sue Lillis; Christoffer Jonsrud; Sigurd Lindal; Erik-Jan Kamsteeg; Martin Lammens; Marcus Broman; Gabriele Dekomien; Paul Maddison; Francesco Muntoni; Caroline Sewry; Aleksandar Radunovic; Marianne de Visser; Volker Straub; Baziel van Engelen; Heinz Jungbluth
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

8.  JP-45/JSRP1 variants affect skeletal muscle excitation-contraction coupling by decreasing the sensitivity of the dihydropyridine receptor.

Authors:  Toshimichi Yasuda; Osvaldo Delbono; Zhong-Min Wang; Maria L Messi; Thierry Girard; Albert Urwyler; Susan Treves; Francesco Zorzato
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

Review 9.  Triadopathies: an emerging class of skeletal muscle diseases.

Authors:  James J Dowling; Michael W Lawlor; Robert T Dirksen
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

10.  Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum.

Authors:  Diana Xerxes Bharucha-Goebel; Mariarita Santi; Livija Medne; Kristen Zukosky; Kristin Zukosky; Jahannaz Dastgir; Perry B Shieh; Thomas Winder; Gihan Tennekoon; Richard S Finkel; James J Dowling; Nicole Monnier; Carsten G Bönnemann
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.